Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (34)

« Back to Publications

Hepatology at home: a novel pathway for the integrated management of patients with liver disease in the home

Cargill T. et al, (2025), FRONTLINE GASTROENTEROLOGY

The Differential Complement, Fc and Chemokine Receptor Expression of B Cells in IgG4-Related Pancreatobiliary Disease and Primary Sclerosing Cholangitis and Its Relevance for Targeting B Cell Pathways in Disease

Cargill T. et al, (2024), Biomedicines, 12, 2839 - 2839

Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV

Davis C. et al, (2024), Vaccines, 12, 644 - 644

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV

Cargill T. et al, (2023), JHEP Reports, 5, 100885 - 100885

NK cells limit therapeutic vaccine–induced CD8 + T cell immunity in a PD-L1–dependent manner

Diniz MO. et al, (2022), Science Translational Medicine, 14

Therapeutic vaccination for treatment of chronic hepatitis B

Cargill T. and Barnes E., (2021), Clinical and Experimental Immunology, 205, 106 - 118

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study

Marjot T. et al, (2021), Journal of Hepatology, 74, 567 - 577

The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases.

Cargill T. and Culver EL., (2021), Frontiers in immunology, 12

What is the probability that this patient, who presents to a UK hospital, will be diagnosed with Covid-19? Prospective validation of the open-source CovidCalculatorUK resource

Chapman G. et al, (2020)

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study

Webb GJ. et al, (2020), The Lancet Gastroenterology & Hepatology, 5, 1008 - 1016

Systematic Review of the Clinical Outcomes of Iron Reduction in Hereditary Hemochromatosis.

Prabhu A. et al, (2020), Hepatology (Baltimore, Md.), 72, 1469 - 1482

High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry

Moon AM. et al, (2020), Journal of Hepatology, 73, 705 - 708

Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease

Goodchild G. et al, (2020), Clinical Medicine, 20, e32 - e39

The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV

Chinnakannan SK. et al, (2020), Vaccines, 8, 184 - 184

Expansion of a Novel Subset of PD1+CXCR5-CD4+ T Peripheral Helper Cells in IgG4-Related Disease

Cargill T. et al, (2020), Clinical and Translational Gastroenterology, 11, e00111 - e00111

Load More